2465-92-1

Usage

Uses

Used in Pharmaceutical Industry:
1,2,3,4,5,6-hexakis-O-(2-cyanoethyl)hexitol is used as a solubility enhancer for poorly water-soluble drugs, improving their bioavailability and therapeutic efficacy.
Used in Polymer Synthesis:
1,2,3,4,5,6-hexakis-O-(2-cyanoethyl)hexitol is used as a reactive building block in the synthesis of various polymers and copolymers, contributing to the development of new materials with tailored properties.
Used in Hydrogel Preparation:
1,2,3,4,5,6-hexakis-O-(2-cyanoethyl)hexitol is used as a cross-linking agent in the preparation of hydrogels, which are essential in various biomedical applications such as drug delivery and tissue engineering.
Used in Emulsion Stabilization:
1,2,3,4,5,6-hexakis-O-(2-cyanoethyl)hexitol is used as a stabilizer for emulsions, ensuring the stability and performance of emulsion-based products in various industries.
Used in Drug Delivery Systems:
1,2,3,4,5,6-hexakis-O-(2-cyanoethyl)hexitol is used in the design of drug delivery systems, facilitating targeted and controlled release of therapeutic agents, enhancing treatment efficacy and patient compliance.
Used in Tissue Engineering:
1,2,3,4,5,6-hexakis-O-(2-cyanoethyl)hexitol is used in tissue engineering applications, providing structural support and promoting cell growth and tissue regeneration.

Upstream product

• 69-65-8 mannitol 
• 107-13-1 acrylonitrile 
• 50-70-4 D-sorbitol 
• 50-70-4 sorbitol 

Relevant academic research and scientific papers

COPPER COMPLEXES AND THEIR USE AS WOOD PRESERVATIVES

This invention relates to wood preservatives containing copper complexes that significantly reduce the decay of wood, cellulose, hemicellulose, and lignin caused by fungi and insects. The copper complexes include a chelating compound that has amide functional groups derived from hydration of a cyanoethylated compound or carboxylic acid functional groups derived from hydrolysis of a cyanoethylated compound, or both types of groups.

Synthesis of polynuclear azoles linked by ether tethers

Alkylation of NH-triazoles and tetrazoles and cycloaddition of organic and inorganic azides to propargyl ethers bearing a cyano group gave a number of polynuclear heterocyclic systems bridged by ether tethers.

STABILIZATION OF HYDROXYLAMINE CONTAINING SOLUTIONS AND METHOD FOR THEIR PREPARATION

The invention relates to the use of amidoximes for prevention of or stabilization of hydroxylamine compounds against undesired decomposition.

PHARMACEUTICAL COMPOSITIONS

This invention relates to crosslinked amine-containing polymers for binding compounds or ions, and more specifically relates to pharmaceutically acceptable compositions for binding compounds or ions that include crosslinked amine-containing polymers. The pharmaceutically acceptable composition includes, for example, crosslinked polyamine particles, or pharmaceutically acceptable salts thereof, having a particle size distribution wherein greater than 10 vol.% of the particles have a particle size greater than 500 μm.

DENDRIMER COMPOSITIONS

Amine compounds, amine polymers, crosslinked amine polymers and pharmaceutical compositions comprising the same may include polyhydroxy-containing cores that may be substituted with amine groups and may be used to treat hyperphosphatemia or to remove ions from the gastrointestinal tract of animals, including humans.

Copper complexes and their use as wood preservatives

This invention relates to copper complexes that significantly reduce the decay of wood, cellulose, hemicellulose, and lignin caused by fungi. A process for treating such materials with these copper-containing anti-fungal agents is also disclosed.